Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: May 16, 2001
Last updated: September 26, 2015
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2007
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):